Literature DB >> 2695067

Inhibition of hyaluronan uptake in lymphatic tissue by chondroitin sulphate proteoglycan.

C Tzaicos1, J R Fraser, E Tsotsis, W G Kimpton.   

Abstract

Afferent lymph vessels entering the popliteal lymph nodes of sheep were infused with [3H]acetyl-labelled hyaluronan [HA; Mr of (0.85-1.2) x 10(5)] for up to 4 h at a rate of 17.4-23.1 micrograms/h. As much as 22.8 micrograms (99%) of infused [3H]HA was taken up by the node per h and degraded. During this interval it was observed that infused HA polymers of higher Mr were absorbed by the node to a greater degree than those of lower Mr. When proteoglycan monomer (PG; Mr 5 x 10(5); 400 micrograms of hexuronic acid/h) was infused concurrently with [3H]HA, the absolute amount of radioactivity appearing in efferent lymph (i.e. labelled material not absorbed by the node) increased, whereas the amount of labelled metabolites of low Mr was reduced considerably. During this period the Mr distribution of labelled HA in efferent outflow reverted to that of the infused material within 30-60 min. Our findings suggest that PG subunits and their chondroitin sulphate chains compete with HA for uptake into the peripheral lymph node of sheep. This indicates that PG, chondroitin sulphate and HA share the same pathway of elimination in this tissue, and is consistent with the view that the lymph node is involved in the metabolic turnover of normal intracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2695067      PMCID: PMC1133659          DOI: 10.1042/bj2640823

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Novel hyaluronidase from streptomyces.

Authors:  T Ohya; Y Kaneko
Journal:  Biochim Biophys Acta       Date:  1970-03-18

2.  Uptake and degradation of hyaluronan in lymphatic tissue.

Authors:  J R Fraser; W G Kimpton; T C Laurent; R N Cahill; N Vakakis
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

3.  Fractionation of a hyaluronic acid preparation in a density gradient. The isolation and identification of a chondroitin sulphate.

Authors:  P Silpananta; J R Dunstone; A G Ogston
Journal:  Biochem J       Date:  1967-08       Impact factor: 3.857

4.  Size-dependent hyaluronate degradation by cultured cells.

Authors:  P G McGuire; J J Castellot; R W Orkin
Journal:  J Cell Physiol       Date:  1987-11       Impact factor: 6.384

5.  The excretion and degradation of chondroitin 4-sulphate administered to guinea pigs as free chondroitin sulphate and as proteoglycan.

Authors:  P A Revell; H Muir
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857

6.  Spectrophotometric measurement of proteoglycans in osteoarthritic synovial fluid.

Authors:  G J Carroll
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

7.  The properties and turnover of hyaluronan.

Authors:  T C Laurent; J R Fraser
Journal:  Ciba Found Symp       Date:  1986

8.  The degradation of intravenously injected chondroitin 4-sulphate in the rat.

Authors:  K M Wood; F S Wusteman; C G Curtis
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

9.  Binding of chondroitin sulfate, dermatan sulfate and fat-storing cell-derived proteoglycans to rat hepatocytes.

Authors:  H C Kirch; M Lammers; A M Gressner
Journal:  Int J Biochem       Date:  1987

10.  THE ORIGIN OF THE CELLS IN THE EFFERENT LYMPH FROM A SINGLE LYMPH NODE.

Authors:  J G HALL; B MORRIS
Journal:  J Exp Med       Date:  1965-06-01       Impact factor: 14.307

View more
  4 in total

1.  Biosynthesis of glycosaminoglycans and proteoglycans by the lymph node.

Authors:  T J Brown; W G Kimpton; J R Fraser
Journal:  Glycoconj J       Date:  2000-11       Impact factor: 2.916

Review 2.  Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease.

Authors:  L S Lohmander
Journal:  J Anat       Date:  1994-06       Impact factor: 2.610

3.  The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin.

Authors:  Edward N Harris; Janet A Weigel; Paul H Weigel
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

4.  LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.

Authors:  S Banerji; J Ni; S X Wang; S Clasper; J Su; R Tammi; M Jones; D G Jackson
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.